Viatris (VTRS) Raw Materials (2019 - 2026)
Viatris' (VTRS) quarterly Raw Materials came in at $1.5 billion in Q1 2026, up 2.12% year-on-year from $1.4 billion in Q1 2025, and up 3.33% quarter-over-quarter from $1.4 billion in Q4 2025.
Viatris (VTRS) Raw Materials (2019 - 2026) Analysis & Trends
Viatris' Raw Materials history runs 8 years deep, the most recent figure standing at $1.5 billion for Q1 2026.
- On a quarterly basis, Raw Materials rose 2.12% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 2.12% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 5.68% from the prior year.
- Raw Materials improved to $1.5 billion in Q1 2026 per VTRS's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Raw Materials topped out at $1.5 billion in Q2 2025 and bottomed at $417.5 million in Q2 2023.
- The 5-year median for Raw Materials is $868.1 million (2022), against an average of $1.0 billion.
- Across the five-year window, Raw Materials sank 48.15% in 2023 and soared 198.51% in 2024, its largest moves.
- Year by year, Raw Materials stood at $571.5 million in 2022, then advanced by 28.03% to $731.7 million in 2023, then jumped by 83.94% to $1.3 billion in 2024, then increased by 5.68% to $1.4 billion in 2025, then increased by 3.33% to $1.5 billion in 2026.
- Per Business Quant, the three latest VTRS Raw Materials figures stand at $1.5 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.47 Bn |
| Dec 31, 2025 | 1.42 Bn |
| Sep 30, 2025 | 1.51 Bn |
| Jun 30, 2025 | 1.55 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 686.70 Mn |
| Dec 31, 2023 | 731.70 Mn |
| Sep 30, 2023 | 742.40 Mn |
| Jun 30, 2023 | 417.50 Mn |
| Mar 31, 2023 | 667.40 Mn |
| Dec 31, 2022 | 571.50 Mn |
| Sep 30, 2022 | 781.80 Mn |
| Jun 30, 2022 | 805.20 Mn |
| Mar 31, 2022 | 868.10 Mn |
| Dec 31, 2021 | 922.40 Mn |
| Sep 30, 2021 | 955.70 Mn |
| Jun 30, 2021 | 948.20 Mn |